Advanced search
Publication Cover
Expert Review of Hematology Volume 8, 2015 - Issue 6
Submit an article Journal homepage
426
Views
9
CrossRef citations to date
0
Altmetric
Perspectives

What is the status of novel anti-CD20 antibodies for chronic lymphocytic leukemia and are they set to leave rituximab in the shadows?

Maria ChaudhryMedstar Washington Hospital Center, Washington DC, USA
&
Bruce D ChesonMedstar Georgetown University Hospital, Washington DC, USACorrespondence[email protected]
Pages 733-742 | Published online: 14 Sep 2015

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Chunyan Luan & Baoan Chen. (2019) Clinical application of obinutuzumab for treating chronic lymphocytic leukemia. Drug Design, Development and Therapy 13, pages 2899-2909.
Read now
Othman Al-Sawaf, Kirsten Fischer, Anja Engelke, Natali Pflug, Michael Hallek & Valentin Goede. (2017) Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy. Drug Design, Development and Therapy 11, pages 295-304.
Read now
Solomon A. Graf & Ajay K. Gopal. (2016) Idelalisib for the treatment of non-Hodgkin lymphoma. Expert Opinion on Pharmacotherapy 17:2, pages 265-274.
Read now

Articles from other publishers (6)

Antonella Interdonato, Sylvie Choblet, Mirco Sana, Rut Valgardsdottir, Sabrina Cribioli, Rachele Alzani, Muriel Roth, Martine Duonor-Cerutti & Josée Golay. (2022) BL-01, an Fc-bearing, tetravalent CD20 × CD5 bispecific antibody, redirects multiple immune cells to kill tumors in vitro and in vivo. Cytotherapy 24:2, pages 161-171.
Crossref
Sanyog Jain, Kaisar Raza, Ashish Kumar Agrawal & Ankur Vaidya. 2021. Nanotechnology Applications for Cancer Chemotherapy. Nanotechnology Applications for Cancer Chemotherapy 547 587 .
Josselin Bernard, Fanny Lalieve, Julie Sarlat, Justine Perrin, Laurene Dehoux, Olivia Boyer, Astrid Godron-Dubrasquet, Jerome Harambat, Stephane Decramer, Mathilde Caillez, Alexandra Bruel, Emma Allain-Launay, Jacques Dantal & Gwenaëlle Roussey. (2020) Ofatumumab treatment for nephrotic syndrome recurrence after pediatric renal transplantation. Pediatric Nephrology 35:8, pages 1499-1506.
Crossref
Jenny O’Nions & William Townsend. (2019) The role of obinutuzumab in the management of follicular lymphoma. Future Oncology 15:31, pages 3565-3578.
Crossref
Fengting Yan, Ajay Gopal & Solomon Graf. (2017) Targeted Drugs as Maintenance Therapy after Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma. Pharmaceuticals 10:4, pages 28.
Crossref
Kanti R. Rai & Preetesh Jain. (2016) Chronic lymphocytic leukemia (CLL)-Then and now. American Journal of Hematology 91:3, pages 330-340.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.